The targets (Jun, HSP90AA1, MMP2, HIF1A, EGFR, RelA, NFKB1, AR, IL6, PIK3CA, MAPK1, TP53, and MAPK3) were enriched in the pathways in cancer. Here, MAPK3 is linked to cancer.